Recent advances in hydrophilic interaction chromatography for quantitative analysis of endogenous and pharmaceutical compounds in plasma samples

Bioanalysis

Volumn 6, Issue 18, 2014, Pages 2421-2439

  Isokawa, Muneki ^a   Kanamori, Takahiro ^a   Funatsu, Takashi ^a   Tsunoda, Makoto ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 DEAZANEPLANOCIN A; ALPRAZOLAM; AMINO ACID; ANASTROZOLE; CAFFEINE; CAPECITABINE; CARBOHYDRATE; CARBOPLATIN; CELECOXIB; CIDOFOVIR; CILASTATIN; COTININE; CYCLOSERINE; CYTARABINE; DAPSONE; DEFERASIROX; FENTANYL; GABOXADOL; IMIPENEM; LESOGABERAN; METFORMIN; METHYLENE BLUE; METHYLPHENIDATE; METOPROLOL; PEPTIDE; PHOSPHOLIPID; TOLBUTAMIDE; TUBERCULOSTATIC AGENT; UNINDEXED DRUG; URACIL ARABINOSIDE; DRUG;

ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HYDROPHILIC INTERACTION CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MASS SPECTROMETRY; PRECIPITATION; PROTEIN PRECIPITATION; QUANTITATIVE ANALYSIS; REVERSED PHASE LIQUID CHROMATOGRAPHY; REVIEW; SEPARATION TECHNIQUE; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL LIQUID CHROMATOGRAPHY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAFILTRATION; BLOOD; BLOOD ANALYSIS; CHEMICAL PHENOMENA; CHEMISTRY; CHROMATOGRAPHY; PROCEDURES;

BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; PHARMACEUTICAL PREPARATIONS;

EID: 84922622690     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.14.173     Document Type: Review

References (118)

1. Alpert AJ. Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds. J. Chromatogr. 499, 177-196 (1990).
2. Gray N, Heaton J, Musenga A, Cowan DA, Plumb RS, Smith NW. Comparison of reversed-phase and hydrophilic interaction liquid chromatography for the quantification of ephedrines using medium-resolution accurate mass spectrometry. J. Chromatogr. A 1289, 37-46 (2013).
3. Kloos D-P, Lingeman H, Niessen WMA, Deelder AM, Giera M, Mayboroda OA. Evaluation of different column chemistries for fast urinary metabolic profiling. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 927, 90-96 (2013).
4. Seçilir A, Schrier L, Bijleveld YA et al. Determination of methylphenidate in plasma and saliva by liquid chromatography/tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 923-924, 22-28 (2013).
5. Nguyen HP, Chandel NS, Deberardinis RJ, Schug KA. Hydrophilic interaction liquid chromatography coupled with MS/MS to detect and quantify dicarboxyethyl glutathione, a metabolic biomarker of the fumarate hydratase deficient cancer cell. J. Sep. Sci. 36(20), 3303-3309 (2013).
6. Hemstrom P, Irgum K. Hydrophilic interaction chromatography. J. Sep. Sci. 29(12), 1784-1821 (2006).
7. Ikegami T, Tomomatsu K, Takubo H, Horie K, Tanaka N. Separation efficiencies in hydrophilic interaction chromatography. J. Chromatogr. A 1184(1-2), 474-503 (2008).
8. Jandera P. Stationary and mobile phases in hydrophilic interaction chromatography: a review. Anal. Chim. Acta 692(1-2), 1-25 (2011).
9. Guo Y, Gaiki S. Retention and selectivity of stationary phases for hydrophilic interaction chromatography. J. Chromatogr. A 1218(35), 5920-5938 (2011).
10. Buszewski B, Noga S. Hydrophilic interaction liquid chromatography (HILIC)-A powerful separation technique. Anal. Bioanal. Chem. 402(1), 231-247 (2012).
11. Hydrophilic Interaction Liquid Chromatography (HILIC) and Advanced Applications. Wang PG, He W (Eds). CRC Press, Boca Raton, FL, USA (2011).
12. Liu A, Tweed J, Wujcik CE. Investigation of an on-line twodimensional chromatographic approach for peptide analysis in plasma by LC-MS-MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877(20-21), 1873-1881 (2009).
13. D'Apolito O, Paglia G, Tricarico F et al. Development and validation of a fast quantitative method for plasma dimethylarginines analysis using liquid chromatographytandem mass spectrometry. Clin. Biochem. 41(16-17), 1391-1395 (2008).
14. Hubert C, Houari S, Lecomte F et al. Development and validation of a sensitive solid phase extraction/hydrophilic interaction liquid chromatography/mass spectrometry method for the accurate determination of glucosamine in dog plasma. J. Chromatogr. A 1217(19), 3275-3281 (2010).
15. Karlsson G, Hinz AC, Winge S. Determination of the stabilizer sucrose in a plasma-derived antithrombin process solution by hydrophilic interaction chromatography with evaporative light-scattering detection. J. Chromatogr. Sci. 42(7), 361-365 (2004).
16. Cifkova E, Holcapek M, Lisa M et al. Nontargeted quantitation of lipid classes using hydrophilic interaction liquid chromatography-electrospray ionization mass spectrometry with single internal standard and response factor approach. Anal. Chem. 84(22), 10064-10070 (2012).
17. Losito I, Patruno R, Conte E, Cataldi TR, Megli FM, Palmisano F. Phospholipidomics of human blood microparticles. Anal. Chem. 85(13), 6405-6413 (2013).
18. Dugo P, Fawzy N, Cichello F, Cacciola F, Donato P, Mondello L. Stop-flow comprehensive two-dimensional liquid chromatography combined with mass spectrometric detection for phospholipid analysis. J. Chromatogr. A 1278, 46-53 (2013).
19. Wang S, Li J, Shi X, Qiao L, Lu X, Xu G. A novel stop-flow two-dimensional liquid chromatography-mass spectrometry method for lipid analysis. J. Chromatogr. A 1321, 65-72 (2013).
20. Peng M, Liu L, Jiang M et al. Measurement of free carnitine and acylcarnitines in plasma by HILIC-ESI-MS/MS without derivatization. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 932, 12-18 (2013).
21. Petteys BJ, Graham KS, Parnas ML, Holt C, Frank EL. Performance characteristics of an LC-MS/MS method for the determination of plasma metanephrines. Clin. Chim. Acta 413(19-20), 1459-1465 (2012).
22. Lang R, Wahl A, Skurk T et al. Development of a hydrophilic liquid interaction chromatography-high-performance liquid chromatography-tandem mass spectrometry based stable isotope dilution analysis and pharmacokinetic studies on bioactive pyridines in human plasma and urine after coffee consumption. Anal. Chem. 82(4), 1486-1497 (2010).
23. D'Apolito O, Garofalo D, La Marca G, Dello Russo A, Corso G. Reference intervals for orotic acid in urine, plasma and dried blood spot using hydrophilic interaction liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 883-884, 155-160 (2012).
24. Ivanisevic J, Zhu ZJ, Plate L et al. Toward 'omic scale metabolite profiling: a dual separation-mass spectrometry approach for coverage of lipid and central carbon metabolism. Anal. Chem. 85(14), 6876-6884 (2013).
25. Spagou K, Tsoukali H, Raikos N, Gika H, Wilson ID, Theodoridis G. Hydrophilic interaction chromatography coupled to MS for metabonomic/metabolomic studies. J. Sep. Sci. 33(6-7), 716-727 (2010).
26. Garbis SD, Melse-Boonstra A, West CE, Van Breemen RB. Determination of folates in human plasma using hydrophilic interaction chromatography-tandem mass spectrometry. Anal. Chem. 73(22), 5358-5364 (2001).
27. Sriboonvorakul N, Leepipatpiboon N, Dondorp AM et al. Liquid chromatographic-mass spectrometric method for simultaneous determination of small organic acids potentially contributing to acidosis in severe malaria. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 941, 116-122 (2013).
28. Benton CM, Couchman L, Marsden JT, Rees DC, Moniz C, Lim CK. Direct and simultaneous quantitation of 5-aminolaevulinic acid and porphobilinogen in human serum or plasma by hydrophilic interaction liquid chromatography-atmospheric pressure chemical ionization/tandem mass spectrometry. Biomed. Chromatogr. 27(2), 267-272 (2013).
29. Lakso H-A, Appelblad P, Schneede J. Quantification of methylmalonic acid in human plasma with hydrophilic interaction liquid chromatography separation and mass spectrometric detection. Clin. Chem. 54(12), 2028-2035 (2008).
30. Turner R, Stamp LK, Kettle AJ. Detection of allantoin in clinical samples using hydrophilic liquid chromatography with stable isotope dilution negative ion tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 891-892, 85-89 (2012).
31. Brown CM, Becker JO, Wise PM, Hoofnagle AN. Simultaneous determination of 6 L-arginine metabolites in human and mouse plasma by using hydrophilic-interaction chromatography and electrospray tandem mass spectrometry. Clin. Chem. 57(5), 701-709 (2011).
32. Shin S, Fung SM, Mohan S, Fung HL. Simultaneous bioanalysis of L-arginine, L-citrulline, and dimethylarginines by LC-MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879(7-8), 467-474 (2011).
33. Jaisson S, Gorisse L, Pietrement C, Gillery P. Quantification of plasma homocitrulline using hydrophilic interaction liquid chromatography (HILIC) coupled to tandem mass spectrometry. Anal. Bioanal. Chem. 402(4), 1635-1641 (2012).
34. Martens-Lobenhoffer J, Bode-Boger SM. Quantification of L-arginine, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma: a step improvement in precision by stable isotope dilution mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 904, 140-143 (2012).
35. Isokawa M, Funatsu T, Tsunoda M. Fast and simultaneous analysis of biothiols by high-performance liquid chromatography with fluorescence detection under hydrophilic interaction chromatography conditions. Analyst 138(13), 3802-3808 (2013).
36. Tsikas D, Schmidt M, Bohmer A, Zoerner AA, Gutzki FM, Jordan J. UPLC-MS/MS measurement of S-nitrosoglutathione (GSNO) in human plasma solves the S-nitrosothiol concentration enigma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 927, 147-157 (2013).
37. Zhu C, Dane A, Spijksma G et al. An efficient hydrophilic interaction liquid chromatography separation of 7 phospholipid classes based on a diol column. J. Chromatogr. A 1220, 26-34 (2012).
38. Scherer M, Bottcher A, Schmitz G, Liebisch G. Sphingolipid profiling of human plasma and FPLC-separated lipoprotein fractions by hydrophilic interaction chromatography tandem mass spectrometry. Biochim. Biophys. Acta 1811(2), 68-75 (2011).
39. Walker SH, Budhathoki-Uprety J, Novak BM, Muddiman DC. Stable-isotope labeled hydrophobic hydrazide reagents for the relative quantification of N-linked glycans by electrospray ionization mass spectrometry. Anal. Chem. 83(17), 6738-6745 (2011).
40. Pucic M, Knezevic A, Vidic J et al. High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Mol. Cell. Proteomics 10(10), M111.010090 (2011).
41. Saldova R, Huffman JE, Adamczyk B et al. Association of medication with the human plasma N-glycome. J. Proteome Res. 11(3), 1821-1831 (2012).
42. Adamczyk B, Struwe WB, Ercan A, Nigrovic PA, Rudd PM. Characterization of fibrinogen glycosylation and its importance for serum/plasma N-glycome analysis. J. Proteome Res. 12(1), 444-454 (2013).
43. Bakovic MP, Selman MH, Hoffmann M et al. Highthroughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides. J. Proteome Res. 12(2), 821-831 (2013).
44. Chandler KB, Pompach P, Goldman R, Edwards N. Exploring site-specific N-glycosylation microheterogeneity of haptoglobin using glycopeptide CID tandem mass spectra and glycan database search. J. Proteome Res. 12(8), 3652-3666 (2013).
45. Tousi F, Bones J, Hancock WS, Hincapie M. Differential chemical derivatization integrated with chromatographic separation for analysis of isomeric sialylated N-glycans: a nanohydrophilic interaction liquid chromatography-MS platform. Anal. Chem. 85(17), 8421-8428 (2013).
46. Sowell J, Fuqua M, Wood T. Quantification of total and free carnitine in human plasma by hydrophilic interaction liquid chromatography tandem mass spectrometry. J. Chromatogr. Sci. 49(6), 463-468 (2011).
47. He X, Gabler J, Yuan C, Wang S, Shi Y, Kozak M. Quantitative measurement of plasma free metanephrines by ion-pairing solid phase extraction and liquid chromatographytandem mass spectrometry with porous graphitic carbon column. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879(23), 2355-2359 (2011).
48. Wuhrer M, De Boer AR, Deelder AM. Structural glycomics using hydrophilic interaction chromatography (HILIC) with mass spectrometry. Mass Spectrom. Rev. 28(2), 192-206 (2009).
49. Dejaegher B, Vander Heyden Y. HILIC methods in pharmaceutical analysis. J. Sep. Sci. 33(6-7), 698-715 (2010).
50. Mesmin C, Cholet S, Blanchard A, Chambon Y, Azizi M, Ezan E. Mass spectrometric quantification of AcSDKPNH2 in human plasma and urine and comparison with an immunoassay. Rapid Commun. Mass Spectrom. 26(2), 163-172 (2012).
51. Kalogria E, Pistos C, Panderi I. Hydrophilic interaction liquid chromatography/positive ion electrospray ionization mass spectrometry method for the quantification of alprazolam and alpha-hydroxy-alprazolam in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 942-943, 158-164 (2013).
52. Ji HY, Sohn JH, Lee HS. Hydrophilic interaction chromatography-electrospray ionization tandem mass spectrometric analysis of anastrozole in human plasma and its application to a pharmacokinetic study. Biomed. Chromatogr. 26(2), 261-266 (2012).
53. Zhou Z, Wu X, Wei Q et al. Development and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the simultaneous determination of five first-line antituberculosis drugs in plasma. Anal. Bioanal. Chem. 405(19), 6323-6335 (2013).
54. Liu Y, Li X, Yang C, Tai S, Zhang X, Liu G. UPLC-MSMS method for simultaneous determination of caffeine, tolbutamide, metoprolol, and dapsone in rat plasma and its application to cytochrome P450 activity study in rats. J. Chromatogr. Sci. 51(1), 26-32 (2013).
55. Deenen MJ, Rosing H, Hillebrand MJ, Schellens JH, Beijnen JH. Quantitative determination of capecitabine and its six metabolites in human plasma using liquid chromatography coupled to electrospray tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 913-914, 30-40 (2013).
56. Ito H, Yamaguchi H, Fujikawa A et al. Quantification of intact carboplatin in human plasma ultrafitrates using hydrophilic interaction liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 917-918, 18-23 (2013).
57. Park MS, Shim WS, Yim SV, Lee KT. Development of simple and rapid LC-MS/MS method for determination of celecoxib in human plasma and its application to bioequivalence study. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 902, 137-141 (2012).
58. Lecomte F, Hubert C, Demarche S et al. Comparison of the quantitative performances and measurement uncertainty estimates obtained during method validation versus routine applications of a novel hydrophilic interaction chromatography method for the determination of cidofovir in human plasma. J. Pharm. Biomed. Anal. 57, 153-165 (2012).
59. Jamalapuram S, Vuppala PK, Mesangeau C, McCurdy CR, Avery BA. Determination of a highly selective mixed-affinity sigma receptor ligand, in rat plasma by ultra performance liquid chromatography mass spectrometry and its application to a pharmacokinetic study. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 891-892, 1-6 (2012).
60. Li P, Beck WD, Callahan PM, Terry AV Jr, Bartlett MG. Quantitation of cotinine and its metabolites in rat plasma and brain tissue by hydrophilic interaction chromatography tandem mass spectrometry (HILIC-MS/MS). J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 907, 117-125 (2012).
61. Uchiyama M, Takamatsu Y, Ogata K et al. Simultaneous determination of cytosine arabinoside and its metabolite, uracil arabinoside, in human plasma using hydrophilic interaction liquid chromatography with UV detection. Biomed. Chromatogr. 27(7), 818-820 (2013).
62. Yaroshenko DV, Grigoriev AV, Sidorova AA. Development and validation of a LC-MS/MS method for D-cycloserine determination in human plasma for bioequivalence study. Anal. Bioanal. Chem. 406(3), 923-927 (2014).
63. Sun F, Ong JC, Yu Q, Chan E. Quantification of 3-deazaneplanocin A, a novel epigenetic anticancer agent, in rat biosamples by hydrophilic interaction liquid chromatography-tandem mass spectrometric detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879(3-4), 285-290 (2011).
64. Peer CJ, Rao M, Spencer SD et al. A rapid ultra HPLC-MS/MS method for the quantitation and pharmacokinetic analysis of 3-deazaneplanocin A in mice. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 927, 142-146 (2013).
65. Pligoropoulou H, Vonaparti A, Panderi I. Hydrophilic interaction liquid chromatography/positive ion electrospray mass spectrometry for the quantification of deferasirox, an oral iron chelator, in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 893-894, 114-120 (2012).
66. Almousa AA, Ikeda R, Wada M, Kuroda N, Hanajiri RK, Nakashima K. HPLC-UV method development for fentanyl determination in rat plasma and its application to elucidate pharmacokinetic behavior after i.p. administration to rats. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879(27), 2941-2944 (2011).
67. Sun J, Zhang F, Peng Y, Liu J, Zhong Y, Wang G. Quantitative determination of diterpenoid alkaloid Fuziline by hydrophilic interaction liquid chromatography (HILIC)-electrospray ionization mass spectrometry and its application to pharmacokinetic study in rats. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 913-914, 55-60 (2013).
68. Nielsen CU, Frolund S, Abdulhadi S et al. Sertraline inhibits the transport of PAT1 substrates in vivo and in vitro. Br. J. Pharmacol. 170(5), 1041-1052 (2013).
69. Hu ZY, Boucher BA, Laizure SC, Herring VL, Parker RB, Hickerson WL. Nonvolatile salt-free stabilizer for the quantification of polar imipenem and cilastatin in human plasma using hydrophilic interaction chromatography/quadrupole mass spectrometry with contamination sensitive off-axis electrospray. J. Mass Spectrom. 48(8), 945-950 (2013).
70. Duner K, Bottner P, Norlen AK. Development of analytical methods for the quantification of metabolites of lesogaberan in a MIST investigation. Biomed. Chromatogr. 28(3), 362-368 (2014).
71. Ekdahl A, Aurell-Holmberg A, Castagnoli N Jr. Identification of the metabolites of lesogaberan using linear trap quadrupole orbitrap mass spectrometry and hydrophilic interaction liquid chromatography. Xenobiotica 43(5), 461-467 (2013).
72. Nielsen F, Christensen MM, Brosen K. Quantitation of metformin in human plasma and urine by hydrophilic interaction liquid chromatography and application to a pharmacokinetic study. Ther. Drug Monit. 36(2), 211-217 (2014).
73. Zhang W, Han F, Zhao H, Lin ZJ, Huang QM, Weng N. Determination of metformin in rat plasma by HILIC-MS/MS combined with Tecan automation and direct injection. Biomed. Chromatogr. 26(10), 1163-1169 (2012).
74. Kim SJ, Ha DJ, Koo TS. Simultaneous quantification of methylene blue and its major metabolite, azure B, in plasma by LC-MS/MS and its application for a pharmacokinetic study. Biomed. Chromatogr. 28(4), 518-524 (2014).
75. Secilir A, Schrier L, Bijleveld YA et al. Determination of methylphenidate in plasma and saliva by liquid chromatography/tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 923-924, 22-28 (2013).
76. Xu Y, Fang W, Zeng W, Leijen S, Woolf EJ. Evaluation of dried blood spot (DBS) technology versus plasma analysis for the determination of MK-1775 by HILIC-MS/MS in support of clinical studies. Anal. Bioanal. Chem. 404(10), 3037-3048 (2012).
77. Pidpruzhnykov YV, Sabko VE, Iurchenko VV, Zupanets IA. UPLC-MS/MS method for bioequivalence study of oral drugs of meldonium. Biomed. Chromatogr. 26(5), 599-605 (2012).
78. Huang PW, Liu HT, Hsiong CH et al. Simultaneous determination of nalbuphine and its prodrug sebacoly dinalbuphine ester in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic study in humans. Biomed. Chromatogr. 27(7), 831-837 (2013).
79. Dong J, Liu S, Zhang H, Hua Q, Zhao X, Miao L. Determination of naloxone-3-glucuronide in human plasma and urine by HILIC-MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 942-943, 83-87 (2013).
80. Dobrinas M, Choong E, Noetzli M, Cornuz J, Ansermot N, Eap CB. Quantification of nicotine, cotinine, trans-3'-hydroxycotinine and varenicline in human plasma by a sensitive and specific UPLC-tandem mass-spectrometry procedure for a clinical study on smoking cessation. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879(30), 3574-3582 (2011).
81. Ito H, Yamaguchi H, Fujikawa A et al. A full validated hydrophilic interaction liquid chromatography-tandem mass spectrometric method for the quantification of oxaliplatin in human plasma ultrafiltrates. J. Pharm. Biomed. Anal. 71, 99-103 (2012).
82. Tian F, Wei H, Jia T, Tian H. An improved highly sensitive method to determine low oxyresveratrol concentrations in rat plasma and its pharmacokinetic application. Biomed. Chromatogr. 28(5), 667-672 (2014).
83. Wunnapuk K, Medley GA, Liu X et al. Simple and sensitive liquid chromatography-tandem mass spectrometry methods for quantification of paraquat in plasma and urine: application to experimental and clinical toxicological studies. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879(28), 3047-3052 (2011).
84. Feng S, Zhao Q, Jiang J, Hu P. Determination of phenylephrine in human plasma using ultra-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 915-916, 28-32 (2013).
85. Luan X, Guan YY, Liu YR et al. Development and validation of a quantitative liquid chromatography tandem mass spectrometry assay for pristimerin in rat plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 941, 25-30 (2013).
86. Abbas M, Ahmad L, Shah Y, Gill M, Watson DG. Development of a method to measure free and bound ropivacaine in human plasma using equilibrium dialysis and hydrophilic interaction chromatography coupled to high resolution mass spectrometry. Talanta 117, 60-63 (2013).
87. Rao RN, Maurya PK, Khalid S. Development of a molecularly imprinted polymer for selective extraction followed by liquid chromatographic determination of sitagliptin in rat plasma and urine. Talanta 85(2), 950-957 (2011).
88. Nirmal J, Velpandian T, Singh SB et al. Development and validation of a highly sensitive LC-MS/MS method for organic cation transporter (OCT) substrate tetraethylammonium (TEA) in rabbits. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879(9-10), 585-590 (2011).
89. Heinig K, Wirz T, Gajate-Perez A, Belli S. Determination of ganciclovir and its prodrug Valganciclovir by hydrophilic interaction liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879(5-6), 436-442 (2011).
90. Lindegardh N, Hanpithakpong W, Kamanikom B et al. Quantification of the anti-influenza drug zanamivir in plasma using high-throughput HILIC-MS/MS. Bioanalysis 3(2), 157-165 (2011).
91. Gilar M, Olivova P, Daly AE, Gebler JC. Orthogonality of separation in two-dimensional liquid chromatography. Anal. Chem. 77(19), 6426-6434 (2005).
92. Nemoto T, Lee XP, Kumazawa T et al. High-throughput determination of nonsteroidal anti-inflammatory drugs in human plasma by HILIC-MS/MS. J. Pharm. Biomed. Anal. 88, 71-80 (2014).
93. Pisano R, Breda M, Grassi S, James CA. Hydrophilic interaction liquid chromatography-APCI-mass spectrometry determination of 5-fluorouracil in plasma and tissues. J. Pharm. Biomed. Anal. 38(4), 738-745 (2005).
94. Kall MA, Fu I, Dige T, Vallano P, Woolf E, Jørgensen M. Development and validation of a selective and sensitive bioanalytical procedure for the quantitative determination of gaboxadol in human plasma employing mixed mode solid phase extraction and hydrophilic interaction liquid chromatography with tandem mass spectroscopic detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 858(1-2), 168-176 (2007).
95. Han PY, Shaw PN, Kirkpatrick CMJ. Determination of para-aminohippuric acid (PAH) in human plasma and urine by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877(27), 3215-3220 (2009).
96. Lee HW, Ji HY, Park ES, Lee KC, Lee HS. Hydrophilic interaction chromatography-tandem mass spectrometric analysis of irbesartan in human plasma: application to pharmacokinetic study of irbesartan. J. Sep. Sci. 32(14), 2353-2358 (2009).
97. Park M-S, Shim W-S, Yim S-V, Lee K-T. Development of simple and rapid LC-MS/MS method for determination of celecoxib in human plasma and its application to bioequivalence study. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 902, 137-141 (2012).
98. Li Y, Zhang X, Wang X, Li S, Ruan J, Zhang Z. Quantification of peramivir (a novel anti-influenza drug) in human plasma by hydrophilic interaction chromatography/tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877(10), 933-938 (2009).
99. Liu Y, Zhang W, Yang Y. Validated hydrophilic interaction LC-MS/MS method for simultaneous quantification of dacarbazine and 5-amino-4-imidazole-carboxamide in human plasma. Talanta 77(1), 412-421 (2008).
100. Zauner G, Deelder AM, Wuhrer M. Recent advances in hydrophilic interaction liquid chromatography (HILIC) for structural glycomics. Electrophoresis 32(24), 3456-3466 (2011).
101. Lindegardh N, Hanpithakpong W, Wattanagoon Y, Singhasivanon P, White NJ, Day NPJ. Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 859(1), 74-83 (2007).
102. Bengtsson J, Jansson B, Hammarlund-Udenaes M. On-line desalting and determination of morphine, morphine-3-glucuronide and morphine-6-glucuronide in microdialysis and plasma samples using column switching and liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 19(15), 2116-2122 (2005).
103. Kumar A, Heaton JC, McCalley DV. Practical investigation of the factors that affect the selectivity in hydrophilic interaction chromatography. J. Chromatogr. A 1276, 33-46 (2013).
104. Chirita RI, West C, Finaru AL, Elfakir C. Approach to hydrophilic interaction chromatography column selection: application to neurotransmitters analysis. J. Chromatogr. A 1217(18), 3091-3104 (2010).
105. Periat A, Debrus B, Rudaz S, Guillarme D. Screening of the most relevant parameters for method development in ultrahigh performance hydrophilic interaction chromatography. J. Chromatogr. A 1282, 72-83 (2013).
106. Apostolou C, Kousoulos C, Dotsikas Y, Loukas YL. Comparison of hydrophilic interaction and reversedphase liquid chromatography coupled with tandem mass spectrometric detection for the determination of three pharmaceuticals in human plasma. Biomed. Chromatogr. 22(12), 1393-1402 (2008).
107. Oh JH, Lee YJ. Sample preparation for liquid chromatographic analysis of phytochemicals in biological fluids. Phytochem. Anal. 25(4), 314-330 (2014).
108. Tulipani S, Llorach R, Urpi-Sarda M, Andres-Lacueva C. Comparative analysis of sample preparation methods to handle the complexity of the blood fluid metabolome: when less is more. Anal. Chem. 85(1), 341-348 (2013).
109. Ruta J, Rudaz S, McCalley DV, Veuthey JL, Guillarme D. A systematic investigation of the effect of sample diluent on peak shape in hydrophilic interaction liquid chromatography. J. Chromatogr. A 1217(52), 8230-8240 (2010).
110. Periat A, Boccard J, Veuthey JL, Rudaz S, Guillarme D. Systematic comparison of sensitivity between hydrophilic interaction liquid chromatography and reversed phase liquid chromatography coupled with mass spectrometry. J. Chromatogr. A 1312, 49-57 (2013).
111. Ekdahl A, Johansson MC, Ahnoff M. Tracing and separating plasma components causing matrix effects in hydrophilic interaction chromatography-electrospray ionization mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 923-924, 83-91 (2013).
112. Song Q, Junga H, Tang Y et al. Automated 96-well solid phase extraction and hydrophilic interaction liquid chromatography-tandem mass spectrometric method for the analysis of cetirizine (ZYRTEC) in human plasma-with emphasis on method ruggedness. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 814(1), 105-114 (2005).
113. Hsieh Y, Chintala M, Mei H et al. Quantitative screening and matrix effect studies of drug discovery compounds in monkey plasma using fast-gradient liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 15(24), 2481-2487 (2001).
114. Kuhlmann FE, Apffel A, Fischer SM, Goldberg G, Goodley PC. Signal enhancement for gradient reverse-phase highperformance liquid chromatography-electrospray ionization mass spectrometry analysis with trifluoroacetic and other strong acid modifiers by postcolumn addition of propionic acid and isopropanol. J. Am. Soc. Mass Spectrom. 6(12), 1221-1225 (1995).
115. Shou WZ, Naidong W. Simple means to alleviate sensitivity loss by trifluoroacetic acid (TFA) mobile phases in the hydrophilic interaction chromatography-electrospray tandem mass spectrometric (HILIC-ESI/MS/MS) bioanalysis of basic compounds. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 825(2), 186-192 (2005).
116. Aoyama C, Saeki A, Noguchi M et al. Use of folded micromachined pillar array column with low-dispersion turns for pressure-driven liquid chromatography. Anal. Chem. 82(4), 1420-1426 (2010).
117. Song Y, Noguchi M, Takatsuki K et al. Integration of pillar array columns into a gradient elution system for pressure-driven liquid chromatography. Anal. Chem. 84(11), 4739-4745 (2012).
118. Song Y, Takatsuki K, Isokawa M et al. Fast and quantitative analysis of branched-chain amino acids in biological samples using a pillar array column. Anal. Bioanal. Chem. 405(25), 7993-7999 (2013).